Links referenced on this page
|
Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and Infectious Diseases Society of America
|
|
https://www.cdc.gov/MMWR/PDF/rr/rr5412.pdf
|
Diagnosis and Classification of Tuberculosis in Adults and Children
|
|
https://www.cdc.gov/tb/publications/PDF/1376.pdf
|
Guidelines on the Diagnosis and Treatment of Pulmonary Nontuberculous Mycobacterial Infection.
|
|
http://www.thoracic.org/statements/resources/mtpi/nontuberculous-mycobacterial-diseases.pdf
|
Guidelines for Environmental Infection Control in Health-Care Facilities, 2003
|
|
https://www.cdc.gov/MMWR/PDF/rr/rr5210.pdf
|
Guidelines for Preventing the Transmission of
|
|
https://www.cdc.gov/tb/publications/guidelines/infectioncontrol.htm
|
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis
|
|
https://www.cdc.gov/mmwr/pdf/rr/rr5415.pdf
|
Hepatotoxicity of Antituberculosis Therapy (2006)
|
|
http://www.thoracic.org/statements/resources/mtpi/hepatotoxicity-of-antituberculosis-therapy.pdf
|
Recommendations for Use of an Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection (cdc.gov)
|
|
https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6048a3.htm
|
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
|
|
https://www.cdc.gov/mmwr/PDF/rr/rr5509.pdf
|
Targeted TB Testing and Treatment of Latent Tuberculosis Infection
|
|
https://www.cdc.gov/MMWR/PDF/rr/rr4906.pdf
|
Treatment of Drug Susceptible Tuberculosis
|
|
https://www.cdc.gov/MMWR/PDF/rr/rr5211.pdf
|
Treatment of Drug-Resistant Tuberculosis
|
|
https://www.cdc.gov/tb/publications/guidelines/mdr_tb.htm
|
Guidelines for the Treatment of Latent Tuberculosis Infection
|
|
https://www.cdc.gov/tb/topic/testing/healthcareworkers.htm
|
Tuberculosis and Air Travel Guidelines for Prevention and Control, Second Edition
|
|
http://www.who.int/tb/publications/2008/WHO_HTM_TB_2008.399_eng.pdf
|
Updated Guidelines for Using Interferon Gamma Release Assays to Detect
|
|
https://www.cdc.gov/mmwr/PDF/rr/rr5905.pdf
|
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
|
|
https://www.cdc.gov/mmwr/PDF/wk/mm5801.pdf
|
Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel
|
|
https://www.cdc.gov/mmwr/volumes/69/rr/rr6901a1.htm
|
World Health Organization, TB website
|
|
http://www.who.int/gtb/index.htm
|
International Union Against TB and Lung Disease
|
|
http://www.theunion.org/
|
Stop TB Partnership
|
|
http://www.stoptb.org/
|
Public Health Image Library(PHIL) (cdc.gov)
|
|
https://phil.cdc.gov/AdvancedSearchResults.aspx?Search=Lung%20Diseases&parentid=22510&catid=15628
|
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination
|
|
https://www.cdc.gov/tb/
|
American Lung Association
|
|
https://www.lung.org
|
Ending Neglect: The Elimination of Tuberculosis in the United States (2000)
|
|
http://www.nap.edu/books/0309070287/html
|
Controlling Tuberculosis in the United States: Recommendations from the American Thoracic Society, CDC, and Infectious Diseases Society of America
|
|
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5412a1.htm
|